Audience Discussion: Exploring Artificial Intelligence to Read Histology Samples for NASH

Time: 9:00 am
day: Day Two


For years pathologists have led the way when it comes to reading histology samples for NASH but the arrival of artificial intelligence is sparking up a debate amongst NASH drug developers across the globe. What exactly is AI going to do? How will that work? Where is biopharma included in its design? What’s the state of the art on AI assessment of pathology, both from a scientific perspective and regulatory perspective? Attend this interactive, discursive session to debate your ideas on this topical subject with your peers and leave with the knowledge you need to cultivate an informed opinion of one of the most important issues for NASH drug developers to date.